PDE5A and type 2 diabetes mellitus: Recent clinical evidence suggest that PDE5 inhibitors may improve glycaemic control by enhancing endothelial function, which could lead to improved glucose transport and insulin sensitivity.5, 6, 7 These inhibitors also reduce inflammation, oxidative stress, and improve nitric oxide production, factors commonly impaired in type 2 diabetes.7